Next Article in Journal
Protective Effect of Salvia miltiorrhiza Extract Against Renal Ischemia-Reperfusion-Induced Injury in Rats
Previous Article in Journal
Primary, Secondary Metabolites, H2O2, Malondialdehyde and Photosynthetic Responses of Orthosiphon stimaneus Benth. to Different Irradiance Levels
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Mild and Efficient Winterfeldt Oxidation of 1,2,3,4-Tetrahydro-γ-carbolines for the Synthesis of Dihydropyrrolo[3,2-b]-quinolones and Pyrrolo[3,2-b]quinolones

ZJU-ENS Joint Laboratory of Medicinal Chemistry, Zhejiang University, Hangzhou 310058, China
*
Author to whom correspondence should be addressed.
Molecules 2012, 17(2), 1177-1190; https://doi.org/10.3390/molecules17021177
Submission received: 5 December 2011 / Revised: 15 January 2012 / Accepted: 17 January 2012 / Published: 30 January 2012

Abstract

:
The Winterfeldt oxidation (NaOH, DMF, air, rt) of substituted 1,2,3,4-tetrahydro-γ-carbolines has been developed, which provides a convenient and efficient method for the synthesis of the corresponding dihydropyrrolo[3,2-b]quinolones in moderate to excellent yields (38–94%). The generality and substrate scope of this reaction are explored and a possible mechanism is proposed. The results imply that electron-withdrawing groups on N2 of tetrahydro-γ-carbolines and N5-H are necessary. The synthesis of 5 or 7-substituted pyrrolo[3,2-b]quinolones in near quantitative yields was also achieved through deprotection and aromatization of N1-boc-dihydropyrrolo[3,2-b]quinolones.

1. Introduction

Fused tricyclic and tetracyclic quinolone scaffolds have been reported to possess many biological properties. For example, pyrroloquinolone 1 is a highly potent and selective PDE5 inhibitor [1], 2,3-dihydro-1H-cyclopenta[b]quinolin-9(4H)-one derivative 2 shows antimalarial activity [2], and cryptolepine analogue 3 displays antiplasmodial activity [3]. Among all the reported synthetic methods for the construction of fused quinolone scaffolds, the biomimetic Winterfeldt oxidation has attracted much interest because of its simple procedure and widely available substrates [4]. Particularly, the Winterfeldt oxidation of 1,2,3,4-tetrahydro-β-carbolines with different reagent systems including NaH/DMF/O2 [5], t-BuOK/DMF/O2 [6], and KO2/18-crown-6/DMF [7,8] was extensively studied in the past few years, which has not only provided an efficient method for the preparation of pyrroloquinolone derivatives such as 1 and 4, but also for crucial indole-quinolone transformations in the total synthesis of potent antitumor agent (±)-camptothecin 5 [9] and TNF production inhibitor (S)-(−)-quinolactacin B 6 [10,11].
As bioisosteres of pyrrolo[3,4-b]quinolones 4, pyrrolo[3,2-b]quinolinones 7 (Figure 1) were first synthesized by Mentel via solid phase Witkop-Winterfeldt oxidation in 2009 [12]. Polymer-bound 2-tosyl-1,2,3,4-tetrahydro-γ-carbolines were converted to ketolactams with ozone in CH2Cl2 at −78 °C, followed by refluxing in Et3N/DMF overnight to yield the target compounds. More recently, the same group reported the scalable solution phase synthesis of pyrrolo[3,4-b]quinolones in low to moderate yield (36–60%) with the same two-step method [13]. However, only the 2-tosyl-1,2,3,4-tetrahydro-γ-carbolines were used as the substrates, so the generality and substrate scope of the reaction have not been extensively explored, and the harsh reaction conditions, tedious procedure with a low to moderate yield of product may limit its wider application. In continuation of our ongoing studies on the synthesis and reactions of γ-carboline derivatives, we report herein the Winterfeldt oxidation of substituted 1,2,3,4-tetrahydro-γ-carbolines under mild reaction conditions (NaOH, DMF, air, rt) [14,15]. The optimized methodology provided for the rapid construction of a variety of substituted dihydropyrrolo[3,2-b]quinolones and pyrrolo[3,2-b] quinolones in good to excellent yields.
Figure 1. Structures of compounds with fused quinolone scaffolds.
Figure 1. Structures of compounds with fused quinolone scaffolds.
Molecules 17 01177 g001

2. Results and Discussion

In our attempt to synthesize compound 9 through alkylation of 2-Boc-1,2,3,4-tetrahydro-γ-carboline 8a with PhCH2CH2Cl in DMF using NaH as the base (Scheme 1), an unexpected product was produced in excellent yield (92%), and the structure was established as 2-Boc-dihydropyrrolo[3,2-b]-quinolone 10a by analysis of the corresponding 1H-NMR, 13C-NMR and MS spectra. We found that no reaction occurred when 8a was stirred with NaH/DMF under nitrogen. This result clearly indicated that a Winterfeldt oxidation of 2-Boc-tetrahydro-γ-1,2,3,4-tetrahydro-carboline had occurred.
Scheme 1. Winterfeldt oxidation of 2-Boc-1,2,3,4-tetrahydro-γ-carboline.
Scheme 1. Winterfeldt oxidation of 2-Boc-1,2,3,4-tetrahydro-γ-carboline.
Molecules 17 01177 g002
Encouraged by this initial finding, we turned our attention towards the development of a convenient and efficient method on the synthesis of dihydropyrrolo[3,2-b]quinolones and pyrrolo[3,2-b]-quinolones via Winterfeldt oxidation.
As shown in Table 1, by using 2-Boc-1,2,3,4-tetrahydro-γ-carboline (8a) as a model compound, a survey of reaction conditions was carried out. We first examined the effect of different bases on the yields of product. The results demonstrated that t-BuOK, NaOCH3, and NaOH were all capable of promoting the Winterfeldt oxidation with almost the same yields of product as NaH, while the reaction using K2CO3 as base failed, probably due to its weak basicity (Table 1, entries 3–6).
Table 1. Optimization of the Winterfeldt oxidation of 2-Boc-1,2,3,4-tetrahydro-γ-carboline.
Table 1. Optimization of the Winterfeldt oxidation of 2-Boc-1,2,3,4-tetrahydro-γ-carboline.
EntryBaseEquiv of baseSolvent Time/hYield (%)
1NaH3.0DMFair494
2NaOH3.0DMFN220
3t-BuOK3.0DMFair495
4MeONa3.0DMFair493
5NaOH3.0DMFair594
6K2CO33.0DMFair240
7NaOH2.0DMFair594
8NaOH1.5DMFair587
9NaOH2.0DMSOair592
10NaOH2.0THFair2035 a
11NaOH2.0MeOHair50
12NaOH2.0DMFO2294
a Reflux, 42% substrate was recovered.
Because of its simple handling and wide availability, NaOH was chosen as the suitable base for the following optimization. Subsequently, the molar ratio of NaOH to substrate 8a was examined, the results suggested that 2.0 equiv. of base was sufficient for this reaction (Table 1, entries 7, 8). A screen of solvents revealed that DMF provided the best yield, MeOH completely inhibited the oxidation, and the yield in THF was poor because of the incomplete conversion of substrate, even under reflux conditions (Table 1, entries 9–11). Usually the Winterfeldt oxidation is carried out with a base in DMF in the presence of oxygen [4,5,6], therefore, a similar reaction with a balloon containing oxygen was performed, and the reaction was complete in 2 h with the same yield as seen in the air. These results suggest that the air performs the same role as the oxygen. (Table 1, entry 12). Considering the convenience of operation and wide availability of reagents, the Winterfeldt oxidation of 2-Boc-1,2,3,4-tetrahydro-γ-carbolines was thus best run in DMF with 2.0 equiv. of NaOH at room temperature for 5 h in the presence of air (Table 1, entry 5). With the optimized reaction conditions, we next examined the generality and substrate scope of this Winterfeldt oxidation reaction. A series of 6- or 8-substituted 2-Boc-1,2,3,4-tetrahydro-γ-carbolines were employed and the diversity of substituents in the 2-position of 1,2,3,4-tetrahydro-γ-carbolines was investigated (Scheme 2).
Scheme 2. Winterfeldt oxidation of 2-substituted-1,2,3,4-tetrahydro-γ-carboline.
Scheme 2. Winterfeldt oxidation of 2-substituted-1,2,3,4-tetrahydro-γ-carboline.
Molecules 17 01177 g003
As shown in Table 2, all the substituted 2-Boc–1,2,3,4-tetrahydro-γ-carbolines examined participate in the Winterfeldt oxidation in excellent yields, which implied that the electronic properties of different substituents in the 6- or 8-position does not affect this transformation very much (Table 2, entries 1–5).
Table 2. Winterfeldt oxidation of substituted 1,2,3,4-tetrahydro-γ-carbolines.
Table 2. Winterfeldt oxidation of substituted 1,2,3,4-tetrahydro-γ-carbolines.
Entry7R1R2Time/hProduct/yield (%)
18aBocH510a (94)
28bBoc8-CH3510b (92)
38cBoc8-OCH3610c (89)
48dBoc8-Br510d (92)
58eBoc6-Cl610e (93)
68fAcH610f (87)
78gBzH710g (89)
88hCbzH610h (86)
98iTsH810i (38)
108jHH24a
118kMeH24a
128lBnH24a
a No desired product was obtained even with NaH/DMF/O2 or t-BuOK/DMF/O2.
The change of substituents in the 2-position has an obvious effect on the yields of products, since while like the 2-Boc substituted derivatives, the 2-acetyl, 2-benzoyl and 2-Cbz substituted 1,2,3,4-tetrahydro-γ-carbolines were converted into the corresponding dihydropyrrolo[3,2-b]quinolones in good yields (86–89%), the yield of the 2-tosyl-dihydropyrrolo[3,2-b]quinolones was only 38%, close to the literature value, perhaps due to the formation of other by-products (Table 2, entries 6–9) [13]. The 2-unsubstituted, 2-methyl and 2-benzyl 1,2,3,4-tetrahydro-γ-carbolines were also evaluated in this reaction, but none of desired products were obtained, even with NaH/DMF/O2 and t-BuOK/DMF/O2 (Table 2, entries 10–12).
All these results imply that electron-withdrawing groups on the 2-position of 1,2,3,4-tetrahydro-γ-carbolines are necessary for this variant of the Winterfeldt oxidation, which may favor the formation of ketolactam intermediates. It also shows that 2-Boc-5-methyl-1,2,3,4-tetrahydro-γ-carboline could not be converted to corresponding quinolone under the optimized conditions, which clearly indicates that prior formation of the N-anion is necessary in this reaction. On the basis of these results and previous studies by Mentel and others [4,13], a plausible mechanism for this improved Winterfeldt oxidation is proposed in Scheme 3.
Scheme 3. Proposed mechanism for the formation of substituted dihydropyrrolo[3,2-b]-quinolones.
Scheme 3. Proposed mechanism for the formation of substituted dihydropyrrolo[3,2-b]-quinolones.
Molecules 17 01177 g004
After a careful survey of reaction conditions, the substituted 2-Boc-dihydropyrrolo[3,2-b]-quinolones 10a–e were refluxed in HCl-EtOAc/CH3OH under nitrogen to afford dihydropyrrolo-[3,2-b]quinolones 11a–e in excellent yields as the corresponding hydrochloride salts. We found that the free amines of 11a–e were unstable in air and part of them transferred to the corresponding pyrrolo[3,2-b]-quinolones 12a–e. Therefore, the conversation of 11a–e to 12a–e in near quantitative yields was accomplished through refluxing in ethanol with K2CO3 (Scheme 4, Table 3).
Scheme 4. Synthesis of dihydropyrrolo[3,2-b]quinolones hydrochloride 11a–e and pyrrolo[3,2-b]quinolones 12a–e.
Scheme 4. Synthesis of dihydropyrrolo[3,2-b]quinolones hydrochloride 11a–e and pyrrolo[3,2-b]quinolones 12a–e.
Molecules 17 01177 g005
Table 3. Synthesis of 11a–e and 12a–e.
Table 3. Synthesis of 11a–e and 12a–e.
Entry10R2Product/yield (%)Product/yield (%)
110aH11a (96)12a (98)
210b8-CH311b (94)12b (97)
310c8-OCH311c (94)12c (96)
410d8-Br11d (95)12d (96)
510e6-Cl11e (94)12e (98)

3. Experimental

3.1. General

All melting points were measured on a Büchi apparatus and were not corrected. IR spectra (KBr pellets, 400–4,000 cm−1) were recorded on a Bruker VECTOR 22 FTIR spectrophotometer. 1H- and 13C-NMR spectra were recorded on a Brucker Avance DMX500 NMR spectrometer (500 and 125 MHz, respectively) using CDCl3, CD3OD, D2O, or DMSO-d6 as solvents with TMS as an internal standard. Elemental analyses were determined with a Thermo-Finnigan Flash EA 1112 elemental analyzer. ESI-HRMS spectra were measured with a Bruker Daltonics Apex β 7.0 FT-ICR MS instrument. Mass spectra (MS, ESI positive) were recorded on an Esquire-LC-00075 spectrometer.

3.2. Synthesis of Substituted tert-Butyl 3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylates 8a–e

A mixture of substituted phenylhydrazine hydrochloride (6.9 mmol) and 4,4-piperidinediol hydrochloride (8.5 mmol) in aqueous HCl solution (20 mL, 2.0 mol/L) was stirred at 60 °C for 16 h. After cooling to room temperature, the mixture was basified to pH > 12 with 25% NaOH solution. The precipitate formed was filtered off, washed with water and petroleum ether, and dried under reduced pressure to give the corresponding substituted 1,2,3,4-tetrahydro-γ-carbolines, which were used in the next step without further purification. To a solution of substituted 1,2,3,4-tetrahydro-γ-carboline in THF (20 mL), di-tert-butyl dicarbonate (8.2 mmol) was added at 0 °C, and the mixture was stirred at rt for 2 h. The solvent was removed under reduced pressure to give the crude product. Purification was performed by column chromatography on silica gel using ethyl acetate/petroleum ether (boiling range 60–90 °C) (1:2, v/v) as eluent to afford compounds 8a–e.
tert-Butyl 3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate (8a) [16]. White solid (1.65 g, 88% yield in two steps); mp 145–146 °C; IR: ν 3,306, 3,065, 2,977, 2,916, 2,838, 1,655, 1,465, 1,428, 1,361, 1,161, 749, 663 cm−1; 1H-NMR (CDCl3): δ 7.97 (s, 1H), 7.46 (d, J = 7.5 Hz, 1H), 7.31 (d, J = 8.0 Hz, 1H), 7.15 (t, J = 7.5 Hz, 1H), 7.10 (t, J = 7.5 Hz, 1H), 4.64 (s, 2H), 3.82 (m, 2H), 2.82 (t, J = 5.5 Hz, 2H), 1.51 (s, 9H); HRMS calculated for C16H21N2O2 [M+H]+: 273.1598, found: 273.1596.
tert-Butyl 8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate (8b) [17]. White solid (1.68 g, 85% yield in two steps); mp 167–168 °C; IR: ν 3,307, 3,012, 2,974, 2,918, 2,839, 1,665, 1,475, 1,431, 1,360, 1,170, 761, 674 cm−1; 1H-NMR (CDCl3): δ 7.81 (s, 1H), 7.23 (s, 1H), 7.19 (d, J = 8.0 Hz, 1H), 6.97 (d, J = 8.0 Hz, 1H), 4.61 (s, 2H), 3.81 (br s,2H), 2.80 (br s, 2H), 2.44 (s, 3H), 1.50 (s, 9H); HRMS calculated for C17H23N2O2 [M+H]+: 287.1754, found: 287.1753.
tert-Butyl 8-methoxy-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate (8c) [18]. White solid (1.81g, 84% yield in two steps); mp 170–171 °C; IR: ν 3,267, 2,972, 2,930, 2,840, 1,657, 1,472, 1,428, 1,368, 1,143, 865 cm−1; 1H-NMR (CDCl3): δ 7.77 (s, 1H), 7.20 (d, J = 8.5 Hz, 1H), 6.89 (d, J = 2.5 Hz, 1H), 6.80 (dd, J1 = 8.5 Hz, J2 = 2.5 Hz, 1H), 4.61 (s, 2H), 3.86 (s, 3H), 3.81 (t, J = 5.5 Hz, 1H), 2.81 (t, J = 5.5 Hz, 1H), 1.51 (s, 9H); HRMS calculated for C17H23N2O3 [M+H]+: 303.1703, found: 303.1702.
tert-Butyl 8-bromo-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate (8d) [19]. Slightly yellow solid (1.99 g, 82% yield in two steps); mp 177–178 °C (lit 177–179 °C); IR: ν 3,287, 3,007, 2,973, 2,926, 2,871, 2,837, 1,668, 1,589, 1,476, 1,461, 1,427, 1,361, 1,291, 1,232, 1,164, 675 cm−1; 1H-NMR (CDCl3): δ 8.11 (s, 1H), 7.55 (s, 1H), 7.21 (d, 1H, J = 8.5 Hz), 7.16 (d, J = 8.5 Hz, 1H), 4.58 (s, 2H), 3.79 (t, J = 5.0 Hz, 1H), 2.81 (t, J = 5.0 Hz, 1H), 1.51 (s, 9H); HRMS calculated for C16H20BrN2O2 [M+H]+: 351.0703, found: 351.0701.
tert-Butyl 6-chloro-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate (8e). White solid (1.84 g, 87% yield in two steps); mp 185–186 °C; IR: ν 3,262, 2,973, 2,924, 2,850, 1,671, 1,625, 1,469, 1,428, 1,361, 1,253, 1,159, 771, 691 cm−1; 1H-NMR (CDCl3): δ 8.17 (s, 1H), 7.34 (d, J = 7.0 Hz, 1H), 7.14 (d, J = 7.5 Hz, 1H), 7.02 (dd, J1 = 8.0 Hz, J2 = 7.5 Hz, 1H), 4.62 (s, 2H), 3.82 (br s, 2H), 2.85 (br s, 2H), 1.51 (s, 9H); 13C NMR (125 MHz, CDCl3): δ 155.1, 133.0, 126.9, 120.8, 120.2, 116.1, 108.4, 80.0, 41.2, 40.4, 28.4, 23.4; HRMS calculated for C16H20ClN2O2 [M+H]+: 307.1208, found: 307.1205.

3.3. Synthesis of Other 2-Substituted-1,2,3,4-tetrahydro-γ-carbolines 8f–i

Acetyl chloride (2.4 mmol) was added dropwise at 0 °C to a solution of 1,2,3,4-tetrahydro-γ-carboline (2.0 mmol) in anhydrous CH2Cl2 (20 mL) containing triethylamine (1.0 mL). The reaction mixture stirred at room temperature until the 1,2,3,4-tetrahydro-γ-carboline disappeared (as monitored by TLC). The solvent and excess reagents were removed under reduced pressure to give the crude product. Purification was performed by column chromatography on silica gel using ethyl acetate/petroleum ether (boiling range 60–90 °C) (2:1, v/v) as eluent to afford 8f. The acetyl chloride was replaced by benzoyl chloride, benzyl chloroformate or p-toluenesulfonyl chloride for the synthesis of 8g, 8h and 8i, respectively.
1-(3,4-Dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)ethanone (8f) [20]. Off-white solid (360 mg, 84% yield); mp 256–257 °C (lit. 256–257 °C); IR: ν 3,143, 3,060, 2,945, 2,866, 1,604, 1,447, 1,359, 1,228, 1,146, 746 cm−1; 1H-NMR (DMSO-d6) analysis revealed the presence of two rotamers present in a 1.5:1 ratio: δ 10.89 (s, 1H, major rotamer), 10.87 (s, 1H, minor rotamer), 7.40 (m, 1H), 7.28 (dd, J1 = 8.0 Hz, J2 = 3.0 Hz, 1H), 7.01–7.05 (m, 1H), 6.95 (dd, J1 = 14.0, J2 = 7.0 Hz, 1H), 4.64 (s, 2H, minor rotamer), 4.62 (s, 2H, major rotamer), 3.83 (t, J = 6.0 Hz, 2H, minor rotamer), 3.76 (t, J = 6.0 Hz, 2H, major rotamer), 2.86 (t, J = 5.5 Hz, 2H, major rotamer), 2.74 (t, J = 5.5 Hz, 2H, minor rotamer), 2.13 (s, 3H, major rotamer), 2.12 (s, 3H, minor rotamer); ESI-MS: m/z 215.07 [M+H]+.
(3,4-Dihydro-1H-pyrido[4,3-b]indol-2(5H)-yl)(phenyl)methanone (8g). Off-white solid (492 mg, 89% yield); mp 204–206 °C; IR: ν 3,198, 3,059, 2,903, 2,840, 1,612, 1,577, 1,444, 1,237, 743, 709 cm−1; 1H NMR (CDCl3) analysis revealed the presence of two rotamers present in a 1.1:1 ratio: δ 8.05 (br s, 1H, major rotamer), 8.02 (br s, 1H, minor rotamer), 7.45–7.53 (m, 5H), 7.25–7.31 (m, 2H), 7.03–7.18 (m, 2H), 4.97 (s, 2H, minor rotamer), 4.66 (s, 2H, major rotamer), 4.16 (br s, 2H, major rotamer), 3.75 (br s, 2H, minor rotamer), 2.98 (br s, 2H, major rotamer), 2.86 (br s, 2H, minor rotamer); 13C-NMR (125 MHz, CDCl3): δ 171.4 (major rotamer), 171.1 (minor rotamer), 136.0 (major rotamer), 135.8 (minor rotamer), 132.4, 130.8, 129.9 (major rotamer), 129.7 (minor rotamer), 128.6 (major rotamer), 128.5 (minor rotamer), 127.1 (major rotamer), 126.7 (minor rotamer), 125.5 (minor rotamer), 124.9 (major rotamer), 121.7 (minor rotamer), 121.6 (major rotamer), 119.6 (minor rotamer), 110.8 (major rotamer), 106.9 (minor rotamer), 106.6 (major rotamer), 45.5 (major rotamer), 45.1 (minor rotamer), 40.3 (major rotamer), 40.2 (minor rotamer), 24.2 (minor rotamer), 23.1 (major rotamer); HRMS (ESI) calculated for C18H17N2O [M+H]+: 277.1335, found: 277.1339.
Benzyl 3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxylate (8h) [21]. White solid (551 mg, 90% yield); mp 115–117 °C; IR: ν 3,387, 3,019, 2,931, 2,858, 1,701, 1,465, 1,434, 1,240, 1,151, 752 cm−1; 1H-NMR (CDCl3): δ 7.91 (br s, 1H), 7.31–7.43 (m, 7H), 7.15 (t, J = 7.5 Hz, 1H), 7.08 (t, J = 7.5 Hz, 1H), 5.20 (s, 2H), 4.73 (s, 2H), 3.87–3.90 (m, 2H), 2.82–2.85 (m, 2H); HRMS (ESI) calculated for C19H19N2O2 [M+H]+: 307.1441, found: 307.1440.
2-Tosyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole (8i) [13]. Light yellow solid (574 mg, 88% yield); mp 187–188 °C (lit. 187–189 °C) 1H-NMR (CDCl3): 7.86 (br s, 1H), 7.50 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 7.5 Hz, 1H), 7.31 (d, J = 8.0 Hz, 2H), 7.26 (d, J = 5.5 Hz, 1H), 7.14 (t, J = 7.5 Hz, 1H), 7.08 (t, J = 7.5 Hz, 1H), 4.38 (s, 2H), 3.51 (t, J = 6.0 Hz, 1H), 2.87 (t, J = 6.0 Hz, 1H), 2.41 (s, 3H).

3.4. Synthesis of Substituted Dihydropyrrolo[3.2-b]quinolones 10a–i

Substituted-1,2,3,4-tetrahydro-γ-carbolines (8a–i, 0.5 mmol), sodium hydroxide powder (1.0 mmol) and anhydrous DMF (5.0 mL) were placed in a 25 mL round-bottomed flask equipped with a calcium chloride drying tube. The mixture was stirred for 5–8 h at room temperature until the substrate disappeared. The reaction mixture was concentrated in vacuo and the residue was partitioned between water (10 mL) and ethyl acetate (20 mL). The organic layer was separated and the aqueous layer was further extracted with ethyl acetate (2 × 20 mL). The combined organic layer was washed with brine (20 mL), dried over Na2SO4 and evaporated in vacuo. The crude product was purified by column chromatography on silica gel using ethyl acetate/petroleum ether (boiling range 60–90 °C) (1:1, v/v) as eluent to give 10a-i.
tert-Butyl 9-oxo-2,3,4,9-tetrahydro-1H-pyrrolo[3,2-b]-quinoline-1-carboxylate (10a). Off-white solid (135 mg, 94% yield); mp 159–161 °C; IR: ν 3,071, 2,984, 2,931, 2,626, 1,687, 1,621, 1,442, 1,380, 1,153, 1,031, 862, 753 cm−1; 1H-NMR (CDCl3): δ 12.47 (s, 1H), 8.23 (d, J = 7.5 Hz, 1H), 7.84 (d, J = 8.5 Hz, 1H), 7.56 (dt, J1 = 8.5 Hz, J2 = 1.8 Hz, 1H), 7.42 (t, J = 7.5 Hz, 1H), 4.02 (t, J = 8.5 Hz, 1H), 3.31 (t, J = 8.5 Hz, 1H), 1.59 (s, 9H); 13C-NMR (CDCl3): δ 157.5, 155.1, 147.1, 145.9, 128.4, 127.6, 124.9, 122.5, 121.5, 117.2, 83.7, 46.4, 30.5, 29.3; ESI-MS: m/z 287.02 [M+H]+; Anal. Calcd for C16H18N2O3: C, 67.12; H, 6.34; N, 9.78; found: C, 67.43; H, 6.48; N, 9.53.
tert-Butyl 7-methyl-9-oxo-2,3,4,9-tetrahydro-1H-pyrrolo[3,2-b]quinoline-1-carboxylate (10b). Off-white solid (138 mg, 92% yield); mp 185–186 °C; IR: ν 2,977, 2,934, 2,646, 1,665, 1,620, 1,569, 1,453, 1,387, 1,150, 1,034, 857 cm−1; 1H-NMR (CDCl3): δ 12.40 (s, 1H), 7.99 (s, 1H), 7.74 (d, J = 8.5 Hz, 1H), 7.38 (dd, J1 = 8.5 Hz, J2 = 2.0 Hz, 1H), 3.99 (t, J = 8.5 Hz, 1H), 3.27 (t, J = 8.5 Hz, 1H), 2.51 (s, 3H), 1.59 (s, 9H); 13C-NMR (CDCl3): δ 156.5, 155.1, 145.6, 145.5, 134.7, 130.6, 127.3, 121.4, 121.3, 171.2, 83.6, 46.4, 30.4, 28.3, 21.6; ESI-MS: m/z 300.94 [M+H]+; Anal. Calcd for C17H20N2O3: C, 67.98; H, 6.71; N, 9.33; found: C, 67.95; H, 6.82; N, 9.41.
tert-Butyl 7-methoxy-9-oxo-2,3,4,9-tetrahydro-1H-pyrrolo[3,2-b]quinoline-1-carboxylate (10c). Off-white solid (141 mg, 89% yield); mp 151–152 °C; IR: ν 3,103, 2,977, 2,931, 2,605, 1,685, 1,659, 1,617, 1,446, 1,392, 1,148, 1,030, 856 cm−1; 1H-NMR (CDCl3): δ 12.46 (s, 1H), 7.75 (d, J = 9.0 Hz, 1H), 7.50 (s, 1H), 7.21 (d, J = 9.0 Hz, 1H), 4.01 (t, J = 8.0 Hz, 1H), 3.93 (s, 3H), 3.28 (t, J = 8.0 Hz, 1H), 1.59 (s, 9H); 13C-NMR (CDCl3): δ 157.0, 155.2, 154.9, 145.0, 142.8, 129.0, 122.2, 120.6, 117.5, 100.6, 83.7, 55.5, 46.6, 30.2, 28.3; ESI-MS: m/z 316.88 [M+H]+; Anal. Calcd for C17H20N2O4: C, 64.54; H, 6.37; N, 8.86; found: C, 64.30; H, 6.48; N, 8.64.
tert-Butyl 7-bromo-9-oxo-2,3,4,9-tetrahydro-1H-pyrrolo[3,2-b]quinoline-1-carboxylate (10d). Light yellow solid (168 mg, 92% yield); mp 179–180 °C; IR: ν 2,979, 2,928, 2,655, 1,664, 1,615, 1,440, 1,379, 1,153, 1,032, 851 cm−1; 1H-NMR (CDCl3): δ 12.49 (s, 1H), 8.37 (d, J = 2.0 Hz, 1H), 7.69 (d, J = 9.0 Hz, 1H), 7.61 (dd, J1 = 9.0 Hz, J2 = 2.0 Hz, 1H), 4.04 (t, J = 8.5 Hz, 2H), 3.30 (t, J = 8.5 Hz, 2H), 1.59 (s, 9H); 13C-NMR (CDCl3): δ 158.0, 155.1, 145.6, 144.9, 131.7, 129.3, 124.9, 122.9, 118.8, 117.8, 84.0, 46.4, 30.4, 28.3; ESI-MS: m/z 364.86 [M+H]+. Anal. Calcd for C16H17BrN2O3: C, 52.62; H, 4.69; N, 7.67; found: C, 52.90; H, 4.72; N, 7.50.
tert-Butyl 5-chloro-9-oxo-2,3,4,9-tetrahydro-1H-pyrrolo[3,2-b]quinoline-1-carboxylate (10e). White solid (149 mg, 93% yield); mp 163–164 °C; IR: ν 2,974, 2,924, 2,672, 1,654, 1,621, 1,441, 1,371, 1,311, 1,157, 1,036, 827, 754 cm−1; 1H-NMR (CDCl3): δ 12.61 (s, 1H), 8.15 (d, J = 8.5 Hz, 1H), 7.66 (d, J = 7.5 Hz, 1H), 7.31 (t, J1 = 8.0 Hz, J2 = 8.0 Hz, 1H), 4.04 (t, J = 8.5 Hz, 2H), 3.40 (t, J = 8.5 Hz, 2H), 1.59 (s, 9H); 13C-NMR (CDCl3): δ 158.5, 155.2, 146.1, 143.3, 131.6, 128.6, 124.7, 123.1, 121.7, 117.9, 84.0, 46.5, 30.8,28.3; ESI-MS: m/z 320.87 [M+H]+; Anal. Calcd for C16H17ClN2O3: C, 59.91; H, 5.34; N, 8.73; found: C, 60.31; H, 5.50; N, 8.82.
1-Acetyl-2,3-dihydro-1H-pyrrolo[3,2-b]quinolin-9(4H)-one (10f). Light yellow solid (99 mg, 87% yield); mp 196–197 °C; IR: ν 3,057, 2,935, 2,363, 1,606, 1,455, 923, 774 cm−1; 1H-NMR (CDCl3): δ 13.14 (s, 1H), 8.26 (d, J = 8.5 Hz, 1H), 7.85 (d, J = 8.5 Hz, 1H), 7.61 (t, J = 7.0 Hz, 1H), 7.45 (t, J = 7.5 Hz, 1H), 4.10 (t, J = 8.5 Hz, 2H), 3.39 (t, J = 8.5 Hz, 2H), 2.33 (s, 3H); 13C-NMR (CDCl3): δ 170.3, 157.2, 148.2, 147.8, 129.3, 127.6, 125.1, 123.3, 121.4, 117.8, 48.0, 30.7, 23.0; ESI-MS: m/z 229.13 [M+H]+; Anal. Calcd for C13H12N2O2: C, 68.41; H, 5.30; N, 12.27; found: C, 68.67; H, 5.46; N, 11.94.
1-Benzoyl-2,3-dihydro-1H-pyrrolo[3,2-b]quinolin-9(4H)-one (10g). Light yellow solid (129 mg, 89% yield); mp 213–214 °C; IR: ν 3,075, 2,995, 2,951, 1,639, 1,582, 1,508, 1,462, 1,389, 1,323, 766 cm−1; 1H-NMR (CDCl3): δ 12.12 (s, 1H), 8.33 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 8.0 Hz, 1H), 7.64–7.66 (m, 3H), 7.48–7.58 (m, 4H), 4.14 (t, J = 8.0 Hz, 2H), 3.32 (t, J = 8.0 Hz, 2H); 13C-NMR (CDCl3): δ 170.3, 157.6, 149.0, 147.8, 134.6, 131.3, 129.6, 128.8, 127.5, 127.2, 125.4, 123.3, 121.7, 118.4, 60.0, 31.3; ESI-MS: m/z 291.14 [M+H]+; Anal. Calcd for C18H14N2O2: C, 74.47; H, 4.86; N, 9.65; found: C, 74.21; H, 4.90; N, 9.58.
Benzyl-9-oxo-2,3,4,9-tetrahydro-1H-pyrrolo[3,2-b]quinoline-1-carboxylate (10h). Light yellow solid (138 mg, 86% yield); mp 153–154 °C; IR: ν 3,115, 2,963, 2,909, 1,669, 1,570, 1,501, 1,473, 1,161, 846, 775, 741 cm−1; 1H-NMR (CDCl3): δ 12.21 (s, 1H), 8.23 (d, J = 8.5 Hz, 1H), 7.84 (d, J = 8.5 Hz, 1H), 7.56–7.59 (m, 1H), 7.35–7.45 (m, 6H), 5.31 (s, 2H), 4.08 (t, J = 8.5 Hz, 2H), 3.31 (t, J = 8.5 Hz, 2H); 13C-NMR (CDCl3): δ 157.2, 155.4, 147.2, 146.0, 135.1, 128.7, 128.6, 128.4, 127.6, 125.1, 122.5, 121.4, 116.6, 69.1, 46.2, 30.4; ESI-MS: m/z 321.12 [M+H]+; Anal. Calcd for C19H16N2O3: C, 71.24; H, 5.03; N, 8.74; found: C, 71.10; H, 5.05; N, 8.59.
1-Tosyl-2,3-dihydro-1H-pyrrolo[3,2-b]quinolin-9(4H)-one (10i) [13]. Light yellow solid (65 mg, 38% yield); mp 207–208 °C (lit. 207–209 °C); 1H-NMR (DMSO-d6): 12.06 (s, 1H), 8.15 (d, J = 7.0 Hz, 1H), 7.65 (d, J = 8.0 Hz, 2H), 7.60 (m, 1H,), 7.46 (d, J = 9.0 Hz, 1H), 7.32–7.35 (m, 3H), 3.99 (t, J = 7.5 Hz, 2H), 2.48–2.50 (m, 2H), 2.36 (s, 3H).

3.5. Synthesis of Dihydropyrrolo[3,2-b]quinolone Hydrochlorides 11a–e

2-Boc-dihydropyrrolo[3,2-b]quinolones (10a–e, 0.5 mmol) was dissolved in a mixture of HCl saturated ethyl acetate (5 mL) and methanol (5 mL) under nitrogen. The reaction mixture was refluxed for 6–8 h and cooled to room temperature, the precipitate was filtered and washed with cool ethyl acetate to afford 11a–e.
2,3-Dihydro-1H-pyrrolo[3,2-b]quinolin-9(4H)-one hydrochloride (11a). Yellow solid (107 mg, 96% yield); mp > 250 °C; IR (KBr): ν 3,091, 2,983, 2,670, 1,635, 1,595, 1,536, 1,465, 1,418, 1,355, 1,266, 756, 682 cm−1. 1H NMR (500 MHz, D2O): δ 8.17 (d, 1H, J = 8.0 Hz), 7.80 (t, 1H, J = 8.0 Hz), 7.54–7.61 (m, 2H), 4.06 (t, J = 7.5 Hz, 2H), 3.58 (t, J = 7.5 Hz, 2H); 13C NMR (125 MHz, D2O): δ 170.2, 150.6, 139.6, 133.2, 125.1, 124.5, 124.0, 118.8, 114.8, 43.8, 28.5; HRMS (ESI) calculated for C11H11N2O [M+H]+: 187.0866, found: 187.0857.
7-Methyl-2,3-dihydro-1H-pyrrolo[3,2-b]quinolin-9(4H)-one hydrochloride (11b). Yellow solid (111 mg, 94% yield); mp > 250 °C; IR (KBr): ν 3,088, 2,988, 2,447, 1,633, 1,570, 1,528, 1,483, 1,418, 1,360, 829 cm−1; 1H NMR (500 MHz, D2O): δ 7.76 (s, 1H), 7.49 (dd, J1 = 8.5 Hz, J2 = 1.5 Hz, 1H), 7.33 (d, J = 8.5 Hz, 1H), 3.94 (t, J = 8.0 Hz, 2H), 3.44 (t, J = 8.0 Hz, 2H), 2.38 (s, 3H); 13C NMR (125 MHz, D2O): δ 169.6, 149.7, 137.4, 135.5, 134.5, 124.2, 122.6, 118.3, 114.6, 43.7, 28.3, 20.2; HRMS (ESI) calculated for C12H12N2NaO [M+Na]+: 223.0842, found: 223.0838.
7-Methoxy-2,3-dihydro-1H-pyrrolo[3,2-b]quinolin-9(4H)-one hydrochloride (11c). Yellow solid (119 mg, 94% yield); mp > 250 °C; IR (KBr): ν 2,813, 2,649, 2,460, 1,613, 1,509, 1,475, 1,348, 1,246, 853 cm−1; 1H NMR (500 MHz, D2O): δ 7.15 (d, J = 9.0 Hz, 1H), 7.11 (s, 1H), 7.03 (d, J = 9.0 Hz, 1H), 3.92 (t, J = 8.0 Hz, 2H), 3.72 (s, 3H), 3.40 (t, J = 8.0 Hz, 2H); 13C NMR (125 MHz, D2O): δ 168.9, 156.3, 149.1, 134.4, 125.6, 123.0, 120.2, 114.4, 103.4, 55.6, 43.9, 28.3; HRMS (ESI) calculated for C12H13N2O2 [M+H]+: 217.0971, found: 217.0964.
7-Bromo-2,3-dihydro-1H-pyrrolo[3,2-b]quinolin-9(4H)-one hydrochloride (11d). Brown solid (143 mg, 95% yield); mp > 250 °C; IR (KBr): ν 2,853, 2,757, 2,469, 1,629, 1,574, 1,518, 1,461, 852 cm−1; 1H NMR (500 MHz, D2O): δ 7.88 (s, 1H), 7.56 (d, J = 8.5 Hz, 1H), 7.20 (d, J = 9.0 Hz,1H), 3.98 (t, J = 8.0 Hz, 2H), 3.53 (t, J = 8.0 Hz, 2H); 13C NMR (125 MHz, D2O): δ 168.8, 151.0, 138.3, 135.5, 126.3, 125.8, 120.6, 117.9, 115.4, 43.7, 28.7; HRMS (ESI) calculated for C11H10BrN2O [M+H]+: 264.9971, found: 264.9969.
5-Chloro-2,3-dihydro-1H-pyrrolo[3,2-b]quinolin-9(4H)-one hydrochloride (11e). Slightly yellow solid (121 mg, 94% yield); mp > 250 °C; IR (KBr): ν 3,084, 2,915, 2,483, 1,630, 1,594, 1,422, 750 cm−1; 1H NMR (500 MHz, D2O): δ 7.80 (d, J = 8.5 Hz, 1H), 7.62 (d, J = 7.5 Hz, 1H), 7.22 (t, 1H, J = 8.0 Hz), 3.95 (t, J = 8.0 Hz, 2H), 3.47 (t, J = 8.0 Hz, 2H); 13C NMR (125 MHz, D2O): δ 170.5, 151.8, 136.9, 133.7, 126.8, 125.8, 124.0, 123.4, 116.6, 49.5, 44.4, 29.7; HRMS (ESI) calculated for C11H10ClN2O [M+H]+: 221.0476, found: 221.0472.

3.6. Synthesis of Pyrrolo[3.2-b]quinolones (12a–e)

Dihydropyrrolo[3,2-b]quinolone hydrochloride (11a–e, 0.5 mmol) was mixed with potassium carbonate (1.0 mmol) in ethanol (10 mL) and refluxed for 4–6 h. The mixture was concentrated in vacuo, the residue was purified by column chromatography on silica gel using ethyl acetate/petroleum ether (boiling range 60–90 °C) (4:1, v/v) as eluent to give 12a–e.
1H-Pyrrolo[3,2-b]quinolin-9(4H)-one (12a) [12]. Light yellow solid (90 mg, 98% yield); mp > 250 °C; IR: ν 3,164, 3,030, 2,900, 1,690, 1,637, 1,595, 1,518, 1,459, 1,413, 750, 669 cm−1; 1H-NMR (DMSO-d6): δ 8.25 (d, J = 7.0 Hz, 1H), 7.56 (dt, J1 = 8.5 Hz, J2 = 1.5 Hz, 1H), 7.49 (d, J = 8.0 Hz, 1H), 7.37 (t, J = 3.0 Hz, 1H), 7.15 (t, J = 7.5 Hz, 1H), 6.20 (t, J = 2.5 Hz, 1H); HRMS (ESI) calculated for C22H17N4O2 [2M+H]+: 369.1346, found: 369.1345.
7-Methyl-1H-pyrrolo[3,2-b]quinolin-9(4H)-one (12b) [12]. Yellow solid (96 mg, 97% yield); mp > 250 °C; IR: ν 3,170, 3,029, 2,930, 1,584, 1,520, 1,475, 1,404, 1,356, 1,302, 1,144, 787 cm−1; 1H-NMR (DMSO-d6): δ 11.77 (s, 1H), 11.66 (s, 1H), 8.05 (s, 1H), 7.36–7.42 (m, 3H), 6.18 (s, 1H), 2.41 (s, 3H); HRMS (ESI) calculated for C12H11N2O [M+H]+: 199.0866, found: 199.0864.
7-Methoxy-1H-pyrrolo[3,2-b]quinolin-9(4H)-one (12c) [12]. Yellow solid (103 mg, 96% yield); mp 250 °C; IR: ν 3,173, 3,015, 2,930, 1,583, 1,522, 1,478, 1,403, 1,356, 1,270, 756 cm−1; 1H-NMR (CD3OD): δ 7.76 (d, J = 2.5 Hz, 1H), 7.45–7.47 (m, 2H), 7.23 (dd, J1 = 9.0 Hz, J2 = 2.5 Hz, 1H), 6.26 (d, J = 3.0 Hz, 1H), 3.86(s, 3H); 13C-NMR (CD3OD): δ 167.3, 155.9, 138.7, 136.0, 131.1, 123.7, 123.2, 121.7, 120.1, 105.0, 95.6, 56.1; HRMS (ESI) calculated for C12H11ClN2O2 [M+H]+: 215.0815, found: 215.0814.
7-Bromo-1H-pyrrolo[3,2-b]quinolin-9(4H)-one (12d) [12]. Yellow solid (126 mg, 96% yield); mp > 250 °C; IR: ν 3,150, 2,924, 1,636, 1,594, 1,514, 1,454, 1,262, 1,153, 1,031, 810, 755 cm−1; 1H-NMR (CD3OD): δ 8.47 (d, J = 2.0 Hz, 1H), 7.65 (dd, 1H, J1 = 9.0 Hz, J2 = 2.0 Hz), 7.48 (d, 1H, J = 3.0 Hz), 7.44 (d, 1H, J = 8.5 Hz), 6.29 (d, 1H, J = 3.0 Hz); 13C-NMR (CD3OD): δ 166.9, 139.5, 138.8, 134.8, 131.3, 128.7, 124.1, 121.7, 120.4, 95.9; HRMS (ESI) calculated for C11H7BrN2O [M+H]+: 262.9815, found: 262.9814.
5-Chloro-1H-pyrrolo[3,2-b]quinolin-9(4H)-one (12e). Yellow solid (107 mg, 98% yield); mp > 250 °C; IR: ν 3,149, 3,023, 2,916, 1,627, 1,583, 1,514, 1,442, 1,355, 1,103, 774 cm−1; 1H-NMR (CD3OD): δ 8.29 (d, J = 8.5 Hz, 1H), 7.63 (d, J = 7.5 Hz, 1H), 7.44 (d, J = 3.0 Hz, 1H), 7.13 (dd, J1 = 8.0 Hz, J2 = 7.5 Hz, 1H), 6.40 (d, J = 3.0 Hz, 1H); 13C-NMR (CD3OD): δ 168.2, 139.1, 137.7, 132.4, 131.6, 126.2, 124.9, 122.9, 122.1, 121.9, 97.3; HRMS (ESI) calculated for C11H7ClN2NaO [M+Na]+; 241.0139, found: 241.0135.

4. Conclusions

In summary, we have reported a convenient and efficient synthesis of dihydropyrrolo[3,2-b]-quinolones and pyrrolo[3,2-b]quinolones via Winterfeldt oxidation of 1,2,3,4-tetrahydro-γ-carbolines. The results suggest that electron-withdrawing groups on the 2-position of 1,2,3,4-tetrahydro-γ-carbolines are necessary for this transformation. Apart from experimental simplicity and excellent yields, it is noteworthy that this is the first report on the classical Winterfeldt oxidation of substituted 1,2,3,4-tetrahydro-γ-carbolines.

Acknowledgements

This work was supported financially by the National Natural Science Foundation of China (21072171) and the Zhejiang Provincial Natural Science Foundation of China (R2110297).
  • Sample Availability: Samples are available from the authors.

References and Notes

  1. Zhihua, S.; Jihua, G.; Mark, J.M.; Weiqin, J.; Suying, Z.; Yuhong, Q.; Patricia, K.; Sheela, B.; Matthew, J.; Donna, H.J.; et al. Pyrroloquinolone PDE5 inhibitors with improved pharmaceutical profiles for clinical studies on erectile dysfunction. J. Med. Chem. 2002, 45, 4094–4096. [Google Scholar] [CrossRef]
  2. Cross, R.; Matthew, M.; Jordany, R.; Mutka, T.S.; Luong, L.; Sargent, J.; Kyle, D.E.; Manetsch, R. Optimization of 1,2,3,4-tetrahydroacridin-9(10H)-ones as antimalarials utilizing structure-activity and structure-property relationships. J. Med. Chem. 2011, 54, 4399–4426. [Google Scholar] [CrossRef]
  3. Lavrado, J.; Paulo, A.; Gut, J.; Rosenthal, P.J.; Moreira, R. Cryptolepine analogues containing basic aminoalkyl side-chains at C-11: Synthesis, antiplasmodial activity, and cytotoxicity. Bioorg. Med. Chem. Lett. 2008, 18, 1378–1382. [Google Scholar] [CrossRef]
  4. Mentel, M.; Breinbauer, R. The witkop-winterfeldt-oxidation of indoles. Curr. Org. Chem. 2007, 11, 159–176. [Google Scholar] [CrossRef]
  5. Wenkert, E.; Dave, K.G.; Lewis, R.G.; Sprague, P.W. General methods of synthesis of indole alkaloids. VI. Syntheses of dl-corynantheidine and a camptothecin model. J. Am. Chem. Soc. 1967, 89, 6741–6745. [Google Scholar] [CrossRef]
  6. Tartrat, C.; Giorgi-Renault, S.; Husson, H.P. A convenient route to quinolone-fused imides and lactams: Synthesis of pyrrolo[3,4-b]quinoline-3,9-diones and 1,3,9-triones by oxidation of indole derivatives. Synlett 1998, 1071–1072. [Google Scholar]
  7. Jiang, W.; Zhang, X.; Sui, Z. Potassium superoxide as an alternative reagent for winterfeldt oxidation of β-Carbolines. Org. Lett. 2003, 5, 43–46. [Google Scholar] [CrossRef]
  8. Shankaraiah, N.; Santos, L.S. Enantioselective total synthesis of pyrroloquinolone as a potent PDE5 inhibitor. Tetrahedron Lett. 2009, 50, 520–523. [Google Scholar] [CrossRef]
  9. Boch, M.; Korth, T.; Nelke, J.M.; Pike, D.; Radunz, H.; Winterfeldt, E. Reaktionen an Indolderivaten, XVII. Die biogenetisch orientierte totalsynthese von DL-Camptothecin und 7-Chlor-camptothecin. Chem. Ber. 1972, 105, 2126–2142. [Google Scholar] [CrossRef]
  10. Zhang, X.; Jiang, W.; Sui, Z. Concise enantioselective syntheses of quinolactacins A and B through alternative winterfeldt oxidation. J. Org. Chem. 2003, 68, 4523–4526. [Google Scholar] [CrossRef]
  11. Shankaraiah, N.; Silva, W.A.; Andrade, C.K.Z.; Santos, L.S. Enantioselective total synthesis of (S)-(-)-Quinolactacin B. Tetrahedron Lett. 2008, 49, 4289–4291. [Google Scholar] [CrossRef]
  12. Mentel, M.; Schmidt, A.M.; Gorray, M.; Eilbracht, P.; Breinbauer, R. Polystyrene sulfonyl chloride: A highly orthogonal linker resin for the synthesis of nitrogen-containing heterocycles. Angew. Chem. Int. Ed. 2009, 48, 5841–5844. [Google Scholar] [CrossRef]
  13. Mentel, M.; Peters, M.; Albering, J.; Breinbauer, R. The Witkope-Winterfeldt oxidation converts tetrahydropyridoindoles into pyrroloquinolones and cinnolines by an unprecedented scaffold rearrangement. Tetrahedron 2011, 67, 965–970. [Google Scholar] [CrossRef]
  14. Chen, J.; Chen, W.L.; Hu, Y.Z. Microwave-enhanced Fischer reaction: An efficient one-pot synthesis of γ-carbolines. Synlett 2004, 77–82. [Google Scholar]
  15. Chen, J.; Liu, T.; Wu, R.; Lou, J.S.; Dong, X.W.; He, Q.J.; Yang, B.; Hu, Y.Z. Design, synthesis, and biological evaluation of novel γ-carboline ketones as anticancer agents. Eur. J. Med. Chem. 2011, 46, 1343–1347. [Google Scholar] [CrossRef]
  16. Fretz, H.; Fecher, A.; Hilpert, K.; Riederer, M. Preparation of tetrahydropyridoindole derivatives as CRTH2 receptor antagonists for the treatment of prostaglandin-mediated diseases. PCT Int. Appl. WO 2005095397, 2005. [Chem. Abstr. 2005, 143, 367289]. [Google Scholar]
  17. Gant, T.G.; Shahbaz, M. Pyridoindole compounds as modulators of NMDA receptor and acetylcholinesterase and their preparation and use in the treatment of diseases. PCT Int. Appl. WO 2010057104, 2010. [Chem. Abstr. 2010, 152, 592014]. [Google Scholar]
  18. Bonjoch, J.; Diaba, F.; Pages, L.; Perez, D.; Soca, L.; Miralpeix, M.; Vilella, D.; Anton, P.; Puig, C. Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists. Bioorg. Med. Chem. Lett. 2009, 19, 4299–4302. [Google Scholar]
  19. Wu, S.G.; Zhang, J.J.; Wu, S.Y.; Xu, W.; Wang, H.T.; Liu, Z.Q.; Wan, S.H. Tetrahydropyridino-indole compounds as c-Met inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. CN 101857594, 2010. [Chem. Abstr. 2010, 153, 580285]. [Google Scholar]
  20. Boksa, J.; Charakchieva-Minol, S.; Duszynska, B.; Bugno, R.; Klodzinska, A.; Tatarczynska, E.; Chojnacka-Wojcik, E.; Bojarski, A. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)-piperazine moiety. Pol. J. Pharmacol. 2003, 55, 1013–1019. [Google Scholar]
  21. Ivashchenko, A.A.; Ivashchenko, A.V.; Tkachenko, S.Y.; Okun, I.M.; Savchuk, N.F. Preparation of derivatives of pyrrolo[4,3-b]indoles, γ-carbolines and azepino[4,3-b]indoles as ligands of 5-HT6 receptors for treating CNS diseases and pharmaceutical compositions containing them. PCT Int. Appl. WO 2008060190, 2008. [Chem. Abstr. 2008, 148, 561890]. [Google Scholar]

Share and Cite

MDPI and ACS Style

Sheng, R.; Zhu, J.; Hu, Y. Mild and Efficient Winterfeldt Oxidation of 1,2,3,4-Tetrahydro-γ-carbolines for the Synthesis of Dihydropyrrolo[3,2-b]-quinolones and Pyrrolo[3,2-b]quinolones. Molecules 2012, 17, 1177-1190. https://doi.org/10.3390/molecules17021177

AMA Style

Sheng R, Zhu J, Hu Y. Mild and Efficient Winterfeldt Oxidation of 1,2,3,4-Tetrahydro-γ-carbolines for the Synthesis of Dihydropyrrolo[3,2-b]-quinolones and Pyrrolo[3,2-b]quinolones. Molecules. 2012; 17(2):1177-1190. https://doi.org/10.3390/molecules17021177

Chicago/Turabian Style

Sheng, Rong, Jiangwei Zhu, and Yongzhou Hu. 2012. "Mild and Efficient Winterfeldt Oxidation of 1,2,3,4-Tetrahydro-γ-carbolines for the Synthesis of Dihydropyrrolo[3,2-b]-quinolones and Pyrrolo[3,2-b]quinolones" Molecules 17, no. 2: 1177-1190. https://doi.org/10.3390/molecules17021177

Article Metrics

Back to TopTop